Advice

Following an abbreviated submission

bimatoprost 0.03%, timolol 0.5% eye drops (Ganfort) are accepted for use in NHS Scotland for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues and for whom this combination offers an appropriate choice.

Download detailed advice28KB (PDF)

Download

Medicine details

Medicine name:
bimatoprost timolol Ganfort
SMC ID:
312/06
Indication:
Reduction of intraocular pressure in patients with open-angle glaucoma or ocular hyper
Pharmaceutical company
Allergan Ltd
BNF chapter
Eye
Submission type
Abbreviated
Status
Accepted
Date advice published
09 October 2006